Diagnostic Approaches and Treatment Options for Gastroparesis
Gastroparesis should be diagnosed using gastric emptying scintigraphy performed for at least 2-4 hours after ingestion of a standardized radiolabeled meal, with treatment tailored to the predominant symptom and severity of delayed emptying. 1, 2
Diagnostic Approach
Definition and Clinical Presentation
- Gastroparesis is defined as delayed gastric emptying in the absence of mechanical obstruction, characterized by symptoms including nausea, vomiting, early satiety, postprandial fullness, bloating, and abdominal pain 2
- The most common etiologies are diabetic (20-40% of diabetic patients), idiopathic (approximately 50% of cases), and postsurgical 2, 3
Diagnostic Testing
Gastric emptying scintigraphy is the gold standard for diagnosis and should be performed for at least 2 hours, with 4-hour testing providing higher diagnostic yield and accuracy 1, 2
The radioisotope must be cooked into the solid portion of the meal (typically a standardized low-fat egg white meal labeled with 99mTc sulfur colloid) 1
Important test preparation considerations:
Alternative diagnostic methods include:
Diagnostic Algorithm
- Rule out mechanical obstruction with upper endoscopy 1, 2
- Perform gastric emptying scintigraphy with proper methodology 2, 1
- Classify gastroparesis severity based on symptoms and degree of emptying delay 2
- Identify the predominant symptom to guide treatment approach 2
Treatment Options
Dietary Modifications
- Smaller, more frequent meals with lower fat and fiber content 1, 3
- Maintain adequate hydration (≥1.5 L fluids/day) 1
- Evaluate eating behaviors (eating too quickly, insufficient chewing, overeating) 1
Pharmacologic Treatment
For Nausea and Vomiting
- Multiple treatment options should be considered for nausea and vomiting 2
- Antiemetic agents such as phenothiazines, 5-HT3 antagonists, and NK-1 receptor antagonists may be used 3, 4
For Gastric Emptying Delay
- Metoclopramide is FDA-approved for diabetic gastroparesis:
- Standard dosing is 10 mg orally up to four times daily before meals and at bedtime 5
- For severe symptoms, initial therapy may begin with metoclopramide injection (IM or IV) 5
- Use with caution in elderly patients and those with renal impairment (reduce dose by half if creatinine clearance <40 mL/min) 5
- Monitor for extrapyramidal side effects, especially in pediatric and elderly populations 5
- Other prokinetic agents include prucalopride and relamorelin 4
For Abdominal Pain
- Neuromodulators should be considered for gastroparesis-associated abdominal pain 2
- Opioids should be avoided as they can worsen gastric emptying 2, 5
- Fundic relaxants (acotiamide, buspirone) may help with symptoms related to impaired gastric accommodation 4
Interventional Approaches for Refractory Cases
- Gastric electrical stimulation (GES) can be considered for patients with refractory/intractable nausea and vomiting who have failed standard therapy and are not on opioids 2
- Gastric per-oral endoscopic myotomy (G-POEM) may be considered for select patients with severe delay in gastric emptying, using a team approach involving motility specialists and advanced endoscopists at centers of excellence 2, 4
Common Pitfalls to Avoid
- Relying solely on symptoms for diagnosis is inadequate as symptoms correlate poorly with the degree of gastric emptying delay 1
- Failure to control blood glucose during testing can lead to false positive results 1
- Not accounting for medications that can affect gastric emptying (prokinetics, opioids, anticholinergics) can lead to inaccurate results 1, 5
- Using opioids for pain management in gastroparesis patients can worsen gastric emptying and symptoms 2, 5